Fathom Therapeutics Closes $55M Series A to Push AI Drug Discovery

Fathom Therapeutics raised an oversubscribed $55M Series A led by Sutter Hill Ventures, with Kos BioVentures joining to scale its quantum chemistry and AI drug-discovery platform.